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Up-Regulation of Interleukin-9 and the Interleukin-9-
Associated Calcium-Activated Chloride Channel hCLCA1 in
Nasal Mucosa Following In Vivo Allergen Challenge
Hans-Peter Hauber, MD, Celine Bergeron, MD, Masao Toda, MD, Mario Kontolemos, BSc, Kenneth J. Holroyd,
Roy C. Levitt, MD, and Qutayba Hamid, MD, PhD
Interleukin (IL)-9 is a pleiotropic T helper 2–type cytokine that has been shown to be up-regulated in allergic airway disease, including
asthma. IL-9 has been demonstrated to be a potent stimulus for the production and secretion of mucus from airway epithelial cells
via induction of a calcium-activated chloride channel, hCLCA1. The objective of this study was to investigate the expression of IL-9
and hCLCA1 following allergen challenge in the nasal mucosa of allergic rhinitis patients. Nasal biopsies were obtained from allergic
rhinitis patients out of allergen season both before (baseline) and after local antigen challenge with either ragweed or diluent
(control). Immunohistochemistry and in situ hybridization were used to assess IL-9 protein and hCLCA1 messenger ribonucleic acid.
Eosinophils and T cells were detected using immunohistochemistry. IL-9 and hCLCA1 were very low at baseline, and expression was
significantly up-regulated following ragweed challenge. Whereas the number of eosinophils increased after allergen challenge, T-cell
counts did not change significantly. The results of this study demonstrate the relationship between specific allergen challenge and
expression of both IL-9 and hCLCA1, suggesting a possible mechanism for the increased production of mucus from airway epithelial
cells in allergic rhinitis.
I
nterleukin (IL)-9 is a pleiotropic T helper 2–type
cytokine that has been shown to be associated with
airway hyperresponsiveness and mucus hypersecretion in
bronchial asthma.
1,2 Animal studies using transgenic IL-9
overexpressing mice have demonstrated that elevated IL-9
levels lead to increased inflammatory cell infiltration
(lymphocytes and eosinophils), goblet cell hyperplasia,
and mucus over-production.
3–5 Instillation of exogenous
IL-9 into the airway of B6 mice was associated with the
specific up-regulation of MUC2 and MUC5AC mucin gene
products.
6 In vitro, stimulation of airway epithelial cells
with IL-9 led to up-regulation of chemokine expression
and induction of several mucin genes, including MUC2
and MUC5AC.
6–8
It was shown in a previous study that the expression
of the calcium-activated chloride channel hCLCA1 in
human primary lung epithelial cells is up-regulated by
IL-9.
9 Transfection of hCLCA1 into human mucoepider-
moid cells resulted in up-regulation of the MUC5AC
gene.
10 Intratracheal administration of adenovirus-expres-
sing antisense ribonucleic acid (RNA) for gob-5
(mCLCA3, the murine counterpart of hCLCA1) into mice
suppressed mucus overproduction following antigen
challenge.
10
Toda and colleagues demonstrated increased protein
levels of IL-9, IL-9 receptor, and messenger ribonucleic
acid (mRNA) levels of hCLCA1 in the airways of asthmatic
patients.
11 In that study, a strong correlation between IL-9,
the IL-9 receptor, and hCLCA1 mRNA was observed.
11
These data strongly support the hypothesis that hCLCA1 is
highly involved in mucus overproduction in airway
inflammatory conditions.
Thus, given the important role that IL-9 plays in the
maintenance of allergic responses and the association of
the IL-9-induced chloride channel hCLCA1 with mucus
overproduction, we sought to characterize the expression
of IL-9 and hCLCA1 in the nasal mucosa of allergic
patients following local specific allergen challenge. We
propose that IL-9 and hCLCA1 expression is increased
after allergen challenge.
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Allergen Challenge and Tissue Collection
Fourteen patients presenting with symptoms of allergic
rhinitis with sensitization for seasonal allergens were
recruited. Allergen sensitization was confirmed by skin-
prick test. Biopsies were obtained from the inferior nasal
turbinate out of season (baseline). After 6 weeks, patients
were challenged with either ragweed (n 5 7) or diluent
(saline, n 5 7) by nasal spray. The second biopsies were
taken 24 hours after challenge. Subjects showed typical
clinical signs of late-phase response following specific
allergen challenge, including sneezing, itchiness, and runny
nose. Tissue was fixed in 4% paraformaldehyde, washed in
a solution of 15% sucrose/phosphate-buffered saline, and
blocked in optimal cutting temperature medium by snap-
freezing in isopentane cooled in liquid nitrogen.
Probe Preparation
Sulphur 35 (S
35)-labeled complementary RNA probe
coding for the murine homologue of hCLCA1 mRNA
was prepared from complementary deoxyribonucleic acid
(cDNA) (Genaera Pharmaceuticals, Plymouth Meeting,
PA), as described previously.
12 In brief, cDNA was inserted
into expression vectors, linearized, and transcribed in vitro
in the presence of S
35-UTP, T7, and SP6 polymerase in
either direction to produce antisense (complementary)
and sense probes (identical to mRNA).
In Situ Hybridization
Sections of nasal mucosa were processed for in situ
hybridization to identify hCLCA1 mRNA, according to the
method of Hamid and colleagues.
12,13 Briefly, after
permeabilization with Triton X-100 and proteinase K
solution (1 mg/mL), sections were prehybridized with 50%
formamide in 23 standard sodium citrate for 15 minutes
at 37uC. Hybridization was carried out overnight at 42uC
with the hybridization mixture containing the appropriate
S
35-labeled sense or antisense probe (0.75 3 10
6 cpm/
slide). Posthybridization involved high-stringency wash-
ings of the samples in decreasing concentrations of
standard saline citrate at 42uC. To remove unbound
RNA probes, the samples were washed with ribonuclease
solution for 20 minutes at 42uC. The samples were then
dehydrated with increasing concentrations of ethanol and
air-dried. After this, the samples were dipped in
Amersham LM-2 emulsion and then exposed for a period
of 14 days. The autoradiographs were then developed in
Kodak D-19 developer, fixed, and counterstained with
periodic acid-Schiff (PAS). The samples were then
mounted with a coverslip and examined under a graduated
microscope for positive signals.
Immunohistochemistry
Immunohistochemistry was used to detect eosinophils, T
cells, and IL-9 immunoreactivity within the sections.
Immunostaining was performed with specific antibodies
to eosinophils (anti-major basic protein [MBP], a gift
from Dr. Moqbel), T cells (anti-CD3; Dako Diagnostics,
Canada), and IL-9 (anti-IL-9, R&D Systems, Minneapolis,
MN) and the alkaline phosphatase-antialkaline phospha-
tase technique, as previously described.
14 For negative
control preparations, the primary antibody was replaced
by either nonspecific immunoglobulin or TRIS-buffered
saline solution.
Quantification
All slides were read blinded (coded), and positive cells
were counted. PAS-positive epithelial cells with hCLCA1
mRNA signals were expressed in a quantification score
from 0 (no positive cells) to 8 (all cells positive). IL-9-,
CD3-, and MBP-immunoreactive cells were expressed as
the number of positive cells per high-powered field
(magnification 3200). The within-observer coefficient of
variation for repeated measures was less than 5%.
Statistical Analysis
The difference in the number of cells expressing hCLCA1
mRNA, IL-9, CD3, or MBP before and after allergen or
saline challenge was compared using Wilcoxon’s signed
rank test. Statistically significant differences between
groups were subsequently analyzed with the Mann-
Whitney U test (Systat, version 7.0, SPSS, Chicago, IL).
The Results are expressed as means 6 SD and were
significant at a p value of less than .05.
Results
Baseline Characteristics
The numbers of T cells, eosinophils, IL-9-positive cells,
and hCLCA1-positive epithelial cells were quantified
before challenge. IL-9 immunoreactivity was localized to
submucosal inflammatory cells. Expression of hCLCA1
was found in the epithelium in mucus-producing cells.
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positive for mucus (90%). Conversely, the majority of
PAS-positive cells showed expression of hCLCA1 (95%).
There was a strong significant correlation between
hCLCA1 and mucus expression (r 5 .93; p , .05).
There was no significant difference before challenge
between the ragweed challenge group and the saline
challenge group (p . .05) (Table 1).
Increase in Eosinophils, IL-9-Positive Cells, and
hCLCA1 Expression Following Allergen Challenge
Following ragweed challenge, there was a sharp increase in
eosinophils, IL-9-positive cells, and hCLCA1-positive
mucous epithelial cells (p , .05) whereas no significant
change occurred after saline challenge (p . .05) (Figures 1
to 3). The numbers of T cells did not change significantly
after ragweed or saline challenge (p . .05) (Figure 4).
Discussion
In this study, we found that specific allergen challenge
significantly increased eosinophils, IL-9-positive cells, and
expression of hCLCA1 in allergic nasal mucosa whereas
saline challenge did not have any significant effect.
We observed increased numbers of eosinophils after
ragweed challenge but not after saline challenge.
Eosinophilic influx after allergen challenge has been
reported.
15 No increase in CD3-positive T cells could be
found in our study. However, activated T cells (CD25
+)
and T helper cells (CD4
+) might be increased after allergen
challenge, as previously shown.
15
The number of IL-9-positive cells was significantly
increased following ragweed challenge whereas saline had
no effect. IL-9 immunoreactivity was localized to sub-
mucosal inflammatory cells. Although we did not perform
colocalization, most of the IL-9-positive cells might be
either T cells (as demonstrated previously)
2 or eosinophils.
No increase in T cells number was detected; thus, T cells
needed to be activated to produce more IL-9 following
allergen challenge. Eosinophils might also be partly
responsible for this increased IL-9 expression. IL-9 was
recently reported to be up-regulated following allergen
Table 1. Numbers of IL-9-Positive Cells, Eosinophils, CD3-
Positive T Lymphocytes, and Epithelial hCLCA1 and Mucus
Expression at Baseline in Both Groups
Saline Challenge
Group (n 5 7)
Ragweed Challenge
Group (n 5 7)
IL-9-positive cells/field 4.1 6 1.9 5.3 6 2.1
Eosinophils/field 3.4 6 1.3 4.6 6 1.7
CD3-positive cells/field 36.7 6 7.5 35.3 6 8.7
hCLCA1 expression 1.7 6 1.0 1.6 6 0.8
Mucus expression 1.3 6 0.9 1.2 6 0.7
IL 5 interleukin
Mean values 6 SD. Epithelial expression of hCLCA1 and mucus is scored
from 0 (no cells) to 8 (all cells).
Figure 1. Interleukin (IL)-9-positive cells in the submucosa before
and after challenge with either saline or ragweed. There is a significant
increase in IL-9-positive cells after ragweed challenge but not after
saline compared with baseline. Value pairs for each patient before and
after challenge are shown by connected dots. Mean values are indicated
by lines. *p , .01.
Figure 2. Expression of hCLCA1 in mucus-producing epithelial cells
before and after challenge with either saline or ragweed. There is a
significant increase in hCLCA1 expression after ragweed challenge but
not after saline compared with baseline. Value pairs for each patient
before and after challenge are shown by connected dots. Mean values
are indicated by lines. *p , .01. Epithelial hCLCA1 expression is
scored from 0 (no cells) to 8 (all cells).
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16 In that study, IL-9-
positive mRNA cells were significantly elevated in the skin
biopsies of atopic subjects at 48 hours after allergen
challenge—a late-phase reaction.
16 However, IL-9 expres-
sion has not been studied in airway tissue following
allergen challenge. Our study showed a marked increase in
IL-9-positive cells at 24 hours, the late-phase reaction,
specific to allergen in human airway mucosa.
IL-9 has been shown to induce mucus production
6,7 by
up-regulation of the expression of hCLCA1.
9 However, IL-
9-induced expression of hCLCA1 has been demonstrated
only in mice and cell culture.
9 In our study, we found
elevated expression of hCLCA1 associated with increased
numbers of IL-9-positive cells following allergen challenge.
These data support previous data showing IL-9-induced
expression of hCLCA1.
9 Moreover, our findings support
the notion that hCLCA1 plays a role in mucus over-
production in allergic airway disease, especially after
exposure to allergen.
Recently, mCLCA3 (the mouse homologue of
hCLCA1) has been reported to be involved in JAK/
STAT6 signalling following stimulation with IL-13.
17 In
that study, niflumic acid, an inhibitor of hCLCA1, reduced
airway inflammation and mucus expression. These data
also show the potential role of hCLCA1 in allergic
inflammation.
In conclusion, this report provides a link between
allergen exposure and increased mucus production via IL-
9-induced expression of hCLCA1. Further studies are
warranted to investigate whether inhibition of either IL-9
or hCLCA1 offers a potential treatment option for mucus
hypersecretion and tissue eosinophilia.
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